Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?
- 1 February 2000
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 4 (1) , 2-5
- https://doi.org/10.1034/j.1399-3046.2000.00093.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sandimmune®to neoral®conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipientsPediatric Transplantation, 1999
- Limited sampling model for area‐under‐the‐curve monitoring in pediatric patients receiving either Sandimmune® or Neoral® cyclosporin A oral formulationsPediatric Transplantation, 1999
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Abbreviated cyclosporine AUCs on Neoral - the search continues!Pediatric Nephrology, 1999
- RANDOMIZED TRIAL OF CYCLOSPORINE MICROEMULSION (NEORAL) VERSUS CONVENTIONAL CYCLOSPORINE IN LIVER TRANSPLANTATIONTransplantation, 1998
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the international neoral® tdm advisory consensus meeting (vancouver, november 1997)Transplantation Proceedings, 1998
- Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to NeoralTransplant International, 1997
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- Practical aspects in the use of cyclosporin in paediatric nephrologyPediatric Nephrology, 1991